The human AHR: Identification of single nucleotide polymorphisms from six ethnic populations

Pharmacogenetics and Genomics

Volumn 20, Issue 5, 2010, Pages 283-290

  Rowlands, Craig J ^a   Staskal, Daniele F ^b   Gollapudi, Bhaskar ^a   Budinsky, Robert ^a  

^a DOW CHEMICAL COMPANY   (United States)

^b ToxStrategies Inc   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Ah receptor; Ethnicity; Polymorphism; Single nucleotide polymorphism

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; HELIX LOOP HELIX PROTEIN;

ARTICLE; CONTROLLED STUDY; ETHNICITY; EXON; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE SEQUENCE; HUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSACTIVATION;

AMINO ACIDS; ETHNIC GROUPS; EXONS; GENETIC VARIATION; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ARYL HYDROCARBON; SEQUENCE ANALYSIS, DNA;

RODENTIA;

EID: 77951432209     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32833605f8     Document Type: Article

References (29)

1. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8- tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 1996; 140:173-179. (Pubitemid 26329475)
2. Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, Glover E, et al. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci USA 2000; 97:10442-10447.
3. Hahn ME. Aryl hydrocarbon receptors: diversity and evolution. Chem Biol Interact 2002; 141:131-160.
4. Poland A, Knutson JC. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 1982; 22:517-554.
5. Kociba RJ, Schwetz BA. A review of the toxicity of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) with a comparison of the toxicity of other chlorinated dioxin isomers. Assoc Food Drug Officials 1981; 46:20.
6. Birnbaum LS, McDonald MM, Blair PC, Clark AM, Harris MW. Differential toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J mice congenic at the Ah locus. Fundam Appl Toxicol 1990; 15:186-200.
7. Ema M, Ohe N, Suzuki M, Mimura J, Sogawa K, Ikawa S, et al. Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J Biol Chem 1994; 269:27337-27343. (Pubitemid 24346556)
8. Poland A, Palen D, Glover E. Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol Pharmacol 1994; 46:915-921. (Pubitemid 24364105)
9. Pohjanvirta R, Tuomisto J. Short-term toxicity of 2,3,7,8- tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol Rev 1994; 46:483-549.
10. Pohjanvirta R, Wong JM, Li W, Harper PA, Tuomisto J, Okey AB. Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin- resistant rat strain. Mol Pharmacol 1998; 54:86-93. (Pubitemid 28337590)
11. Connor KT, Aylward LL. Human response to dioxin: aryl hydrocarbon receptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR. J Toxicol Environ Health B Crit Rev 2006; 9:147-171.
12. Moriguchi T, Motohashi H, Hosoya T, Nakajima O, Takahashi S, Ohsako S, et al. Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc Natl Acad Sci USA 2003; 100:5652-5657. (Pubitemid 36576863)
13. Procopio M, Lahm A, Tramontano A, Bonati L, Pitea D. A model for recognition of polychlorinated dibenzo-p-dioxins by the aryl hydrocarbon receptor. Eur J Biochem 2002; 269:13-18. (Pubitemid 34107334)
14. Tiido T, Rignell-Hydbom A, Jonsson BA, Rylander L, Giwercman A, Giwercman YL. Modifying effect of the AR gene trinucleotide repeats and SNPs in the AHR and AHRR genes on the association between persistent organohalogen pollutant exposure and human sperm Y:X ratio. Mol Hum Reprod 2007; 13:223-229. (Pubitemid 46554739)
15. Kawajiri K, Watanabe J, Eguchi H, Nakachi K, Kiyohara C, Hayashi S. Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 1995; 5:151-158.
16. Anttila S, Lei XD, Elovaara E, Karjalainen A, Sun W, Vainio H, et al. An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes. Pharmacogenetics 2000; 10:741-751.
17. Wong JM, Okey AB, Harper PA. Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem Biophys Res Commun 2001; 288:990-996.
18. Harper PA, Wong JY, Lam MS, Okey AB. Polymorphisms in the human AH receptor. Chem Biol Interact 2002; 141:161-187.
19. Smart J, Daly AK. Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics 2000; 10:11-24. (Pubitemid 30142809)
20. Micka J, Milatovich A, Menon A, Grabowski GA, Puga A, Nebert DW. Human Ah receptor (AHR) gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility. Pharmacogenetics 1997; 7:95-101. (Pubitemid 27261841)
21. Wanner R, Zober A, Abraham K, Kleffe J, Henz BM, Wittig B. Polymorphism at codon 554 of the human Ah receptor: different allelic frequencies in Caucasians and Japanese and no correlation with severity of TCDD induced chloracne in chemical workers. Pharmacogenetics 1999; 9:777-780. (Pubitemid 30011942)
22. Kellermann G, Cantrell E, Shaw CR. Variations in extent of aryl hydrocarbon hydroxylase induction in cultured human lymphocytes. Cancer Res 1973; 33:1654-1656.
23. Smith GB, Harper PA, Wong JM, Lam MS, Reid KR, Petsikas D, et al. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Cancer Epidemiol Biomarkers Prev 2001; 10:839-853. (Pubitemid 32738596)
24. Fujita H, Kosaki R, Yoshihashi H, Ogata T, Tomita M, Hasegawa T, et al. Characterization of the aryl hydrocarbon receptor repressor gene and association of its Pro185Ala polymorphism with micropenis. Teratology 2002; 65:10-18. (Pubitemid 34024454)
25. Watanabe T, Imoto I, Kosugi Y, Fukuda Y, Mimura J, Fujii Y, et al. Human arylhydrocarbon receptor repressor (AHRR) gene: genomic structure and analysis of polymorphism in endometriosis. J Hum Genet 2001; 46:342-346. (Pubitemid 32524632)
26. Manchester DK, Gordon SK, Golas CL, Roberts EA, Okey AB. Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo(a)pyrene. Cancer Res 1987; 47:4861-4868.
27. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 2004; 279:23847-23850.
28. Okey AB, Giannone JV, Smart W, Wong JM, Manchester DK, Parker NB, et al. Binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to AH receptor in placentas from normal versus abnormal pregnancy outcomes. Chemosphere 1997; 34:1535-1547. (Pubitemid 27161629)
29. Schecter AJ BL, Ryan JJ, Constable JB. To the editor. Env Res 2007; 103:147-148.